Deutsche Telekom launches conversational AI platform for European enterprise customer service

Timotheus Höttges Chief Executive Officer Deutsche Telekom AG
Timotheus Höttges Chief Executive Officer - Deutsche Telekom AG
0Comments

Deutsche Telekom has launched Telekom CoMind, a conversational AI platform designed to support European businesses with voice and chat bots that deliver accurate answers based on company knowledge. The platform aims to enhance customer communication through both voice and text, offering advanced analytics and integration options for workflow automation.

Telekom CoMind is built to address challenges in customer service such as staff shortages, peak demand periods, and rising operational costs. By using AI-powered dialog systems, the platform can understand natural language inquiries across multiple channels. It identifies intent, retrieves information from connected systems, and provides real-time responses. Standard questions are handled automatically while more complex issues are directed to human agents.

The system is developed in Europe by Deutsche Telekom and meets strict data protection standards including GDPR and the EU AI Act. Its modular design allows businesses to add services as needed and integrate with existing IT infrastructure.

Elvira Gonzalez, Senior Vice President of Commercial Growth B2B Europe at Deutsche Telekom, said: “With Telekom CoMind, businesses can deliver scalable, high-quality customer interactions powered by trusted European AI. Companies gain tangible proof of how AI improves contact center efficiency while enhancing both customer and employee satisfaction.”

Telekom CoMind incorporates technology from ElevenLabs for natural-sounding conversations in several languages such as Polish, Czech, Slovak, Croatian, Slovenian, Greek, Hungarian, German, English and French. More than 65 additional languages are supported for multilingual service across markets.

Before deployment, the platform’s large language model is trained with client-specific data using Retrieval-Augmented Generation (RAG), ensuring responses are tailored to each business’s knowledge base. The admin interface allows companies to update content easily so that answers remain current.

Analytics dashboards enable organizations to monitor performance metrics like intent recognition accuracy and handovers to human agents for ongoing optimization.

Integration capabilities include connections with legacy systems as well as modern platforms like Cisco Webex. Through a partnership with n8n for workflow automation, CoMind can orchestrate tasks without constant human input.

A notable implementation of Telekom CoMind is at Phoenix Pharma Hungary—a subsidiary of Phoenix Group—which used the solution alongside Cisco Webex to overhaul its contact center operations. Previously operating three separate legacy systems led to inconsistent service levels around 60 percent. After deploying Telekom CoMind’s AI-driven tools—including automated voice authentication and internal support chatbots—Phoenix Pharma improved its Service Level metric above 98 percent while consolidating their operations into one system.

Csaba Marik, IT Director at Phoenix Pharma Hungary stated: “We didn’t just need a software vendor; we needed a partner who understands the critical nature of pharma logistics. Telekom CoMind brought the AI expertise and integration capability all in one hand. The solution allowed us to move from legacy systems to an AI-first operation, boosting our Service Level to over 98 percent and empowering our agents with immediate access to knowledge.”

Phoenix Group operates across 29 European countries with extensive wholesale sites and pharmacy networks.

Deutsche Telekom will present this use case during Mobile World Congress 2026 in Barcelona between March 2-5 at booth 3M31 in hall 3; events will be available via livestream at mwc.telekom.com/2026.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.